Clinical Trials and Commercialization Using CPPs

  • Langel Ü
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Below, a brief summary of the clinical trials and commercialization using the CPP approaches for the delivery of pharmaceuticals is presented. I feel that, due to protective reasons, the available information is not always very clear or well defined. Additionally, the information concerning the initiation and finalization of clinical trials is difficult to obtain and, hence, sometimes the situation in clinical trials is not timely, which is a nightmare for the updated summary of the field. Despite that, several excellent reviews on the subject are available and I hereby rely on them (Johnson et al.

Cite

CITATION STYLE

APA

Langel, Ü. (2019). Clinical Trials and Commercialization Using CPPs. In CPP, Cell-Penetrating Peptides (pp. 395–408). Springer Singapore. https://doi.org/10.1007/978-981-13-8747-0_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free